News
Trial finds Lilly’s Olumiant could treat type 1 diabetes
Treatment with Eli Lilly’s JAK inhibitor Olumiant has been shown to …
19770 items found
News
Sanofi says new drugs can add €10bn to sales by 2030
Sanofi said this morning that its pipeline includes 12 potential …
News
AbbVie swoops on Pfizer spin-out Cerevel with $8.7bn offer
AbbVie has announced its second major takeover deal in the space of a …
Patients
Sponsored
Partnerships for prevention: Biopharma, patients, and digital technology
Anthropy23 returned to The Eden Project in Cornwall for its second …
News
Taisho says $5bn management buyout will rev up business
Japan’s Taisho Pharmaceutical looks like it could be heading into …
Patients
Protecting the immunocompromised: Preventative measures against COVID-19
COVID-19 vaccines are not as effective in immunocompromised …
News
Daiichi Sankyo unit claims $182m in Novartis patent dispute
Novartis has settled a lawsuit brought by Daiichi Sankyo’s Plexxikon …
News
Novartis’ Fabhalta is first FDA-cleared oral therapy for PNH
Novartis’ targeted factor B inhibitor iptacopan has become the first …
News
Merck pummelled as MS hope evobrutinib dies in phase 3
Germany’s Merck KGaA is facing a big hole in its late-stage pipeline …
News
Sanofi expands GenAI drug discovery pact with Aqemia
Sanofi has deepened an existing collaboration with artificial …
R&D
The Oxford R21 malaria vaccine and the imperative of continued malaria testing
Malaria, a disease caused by the plasmodium parasite and transmitted …
Market Access
A strategic approach to local affiliates in the global era
While global harmonisation remains the holy grail, the reality is …
News
Nasdaq debutante Septerna swells its IPO to $331m
Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount raised topping $331 million.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
